摘要 |
<p>The invention concerns a pharmaceutical composition with antitumor activity based on carboplatin, comprising an aqueous solution of carboplatin with the carboplatin content from 1 to 20 mg.ml.-1. The pharmaceutical composition contains, immediately after its preparation, less than 0.1% by weight 1,1-cyclobutanedicarboxylic acid ("CBDCA") and/or salt thereof, based on the weight of the present carboplatin.</p> |